Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1981 1
1983 1
1984 1
1985 1
1987 2
1989 4
1990 4
1991 2
1993 2
1994 7
1995 1
1997 1
1998 1
2001 1
2002 1
2003 1
2005 1
2007 2
2011 2
2015 2
2016 2
2019 1
2020 1
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

46 results
Results by year
Filters applied: . Clear all
Page 1
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.
Marty M, Cognetti F, Maraninchi D, Snyder R, Mauriac L, Tubiana-Hulin M, Chan S, Grimes D, Antón A, Lluch A, Kennedy J, O'Byrne K, Conte P, Green M, Ward C, Mayne K, Extra JM. Marty M, et al. Among authors: mayne k. J Clin Oncol. 2005 Jul 1;23(19):4265-74. doi: 10.1200/JCO.2005.04.173. Epub 2005 May 23. J Clin Oncol. 2005. PMID: 15911866 Clinical Trial.
Genetic variants in complement pathway and ARMS2/HTRA1 genes and risk of age-related macular degeneration in a homogeneous population from central Greece.
Tsiloulis AN, Zacharaki F, Kotoula MG, Chatzoulis DZ, Morrison MA, Mayne K, Dardiotis E, Stefanidis IL, Almpanidou P, DeAngelis MM, Tsironi EE. Tsiloulis AN, et al. Among authors: mayne k. Ophthalmic Genet. 2016 Sep;37(3):339-44. doi: 10.3109/13816810.2015.1045525. Epub 2016 Feb 5. Ophthalmic Genet. 2016. PMID: 26848857 No abstract available.
46 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page